c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Brigham and Women's Hospital · BC Cancer Agency · +6 more institutions
Abstract
Human acute T-cell lymphoblastic leukemias and lymphomas (T-ALL) are commonly associated with gain-of-function mutations in Notch1 that contribute to T-ALL induction and maintenance. Starting from an expression-profiling screen, we identified c-myc as a direct target of Notch1 in Notch-dependent T-ALL cell lines, in which Notch accounts for the majority of c-myc expression. In functional assays, inhibitors of c-myc interfere with the progrowth effects of activated Notch1, and enforced expression of c-myc rescues multiple Notch1-dependent T-ALL cell lines from Notch withdrawal. The existence of a Notch1-c-myc signaling axis was bolstered further by experiments using c-myc-dependent murine T-ALL cells, which are…
Citation impact
- FWCI
- —
- Percentile
- —
- References
- 87
Authors
17- APAndrew P. WengCorresponding
Brigham and Women's Hospital, BC Cancer Agency, Harvard University
- JMJohn M. Millholland
Cancer Research Institute, University of Pennsylvania
- YYYumi Yashiro–Ohtani
Cancer Research Institute, University of Pennsylvania
- MAMarie-Laure Arcangeli
Cancer Research Institute, University of Pennsylvania
- ALArthur Lau
BC Cancer Agency, Terry Fox Research Institute
Topics & keywords
- Biology
- Notch signaling pathway
- T cell
- Cancer research
- Signal transduction
- Jurkat cells
- Lymphoma
- Leukemia
- Good health and well-being